3M Company vs Eli Lilly & Co.
MMM vs LLY — side-by-side comparison from reported financials. MMM leads 3, LLY leads 8 of 11 comparable metrics.
3M Company
MMM · Healthcare
$160.20-2.07%Mixed
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | MMM | LLY |
|---|---|---|
| Price | $160.20 | $1 177.20 |
| Market cap | $82.6B | $1.05T |
| Revenue (TTM) | $25.2B | $79.7B |
| Revenue growth | -1.6% | +31.7% |
| Net margin | 11.9% | 33.5% |
| Free cash flow | $3.98B | $18.2B |
| Net cash (debt) | ($4.67B) | ($35.2B) |
| 1-year price return | +4.8% | +37.6% |
| P/E | 27.5 | 41.6 |
| P/E vs own history (cheap-side %) | 18% | 88% |
| Dividend yield | 1.93% | 0.52% |
| Return on equity | 77% | 93% |
| Altman Z-score | — | 7.10 |
| CV checks passed | 9 of 11 | 11 of 11 |
| Employees | 60,500 | 50,000 |
Full résumé-style profiles: MMM CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.